Physiological properties of the murG gene product of Escherichia coli were investigated. The inactivation of the murG gene rapidly inhibits peptidoglycan synthesis in exponentially growing cells. As a result, various alterations of cell shape are observed, and cell lysis finally occurs when the peptidoglycan content is 40% lower than that of normally growing cells. Analysis of the pools of peptidoglycan precursors reveals the concomitant accumulation of UDP-N-acetylglucosamine (UDP-GlcNAc) and UDP-N-acetylmuramyl-pentapeptide (UDPMurNAc-pentapeptide) and, to a lesser extent, that of undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide (lipid intermediate I), indicating that inhibition of peptidoglycan synthesis occurs after formation of the cytoplasmic precursors. The relative depletion of the second lipid intermediate, undecaprenyl-pyrophosphorylMurNAc-(pentapeptide)GlcNAc, shows that inactivation of the murG gene product does not prevent the formation of lipid intermediate I but inhibits the next reaction in which GlcNAc is transferred to lipid intermediate I. In vitro assays for phospho-MurNAc-pentapeptide translocase and N-acetylglucosaminyl transferase activities finally confirm the identification of the murG gene product as the transferase that catalyzes the conversion of lipid intermediate I to lipid intermediate II in the peptidoglycan synthesis pathway. Plasmids allowing for a high overproduction of the transferase and the determination of its N-terminal amino acid sequence were constructed. In cell fractionation experiments, the transferase is essentially associated with membranes when it is recovered.
The biosynthesis of bacterial cell wall peptidoglycan is a complex process involving many different cytoplasmic and membrane steps (10, 49) . Conditional-lethal mutants altered at different levels of this metabolic pathway have been described previously, and most of the mutations have been mapped (5, 43, 49, 50, 52, 56) . In particular, the 2-min region of the Escherichia coli chromosome contains a large cluster of genes from pbpB to envA that code for proteins involved in different aspects of peptidoglycan synthesis and cell division. The organization of the genes in this cluster is now completely elucidated, and the nucleotide sequence of the whole 17-kbp region has been determined (11-13, 16, 37, 39, 41 ; see reference 35 for references before 1990). The genes, tightly packed and overlapping in many cases, appear in the following order: pbpB-murE-murF-ORF-Y-murD-ftsW-murGmurC-ddl-ftsQ-ftsA-ftsZ-envA. The murC, murD, murE, murF, and ddl gene products were identified previously as L-alanine, D-glutamic acid, meso-2,6-diaminopimelic acid (DAP), D-alanyl-D-alanine-adding enzymes, and D-alanine: D-alanine ligase, respectively (10, 26-28, 32, 35, 43) , which are involved in the synthesis of the soluble nucleotide precursors from UDP-N-acetylmuramic acid (UDP-MurNAc) to UDP-MurNAc-L-Ala-y-D-Glu-meso-DAP-D-Ala-DAla (UDP-MurNAc-pentapeptide). These genes are flanked on the left by a cell division gene named pbpB (1, 52) or ftsI (44) that codes for penicillin-binding protein 3, which is involved in septum formation (17) , and on the right by a * Corresponding author. group of three contiguous genes, ftsQ, ftsA, and ftsZ (see reference 29 for references therein), which are involved in the late steps of the cell division process but whose functions have not yet been clearly identified. Recently, the pbpBmurG region was investigated in more detail, and, in particular, three new genes, ORF-Y (12), murD (35, 39) , and ftsW (11, 16) , were identified.
The murG gene was discovered in this region of the chromosome 10 years ago by Salmond et al. (50) . As judged from the various alterations in cell shape and the lytic thermosensitive phenotype that characterized the corresponding mutant, it was speculated that it may code for a protein involved in peptidoglycan metabolism, but its function was not further investigated. We recently localized more precisely the murG gene within a 1.7-kbp SalI-KpnI fragment (35) originating from plasmid pLC26-6 of the Clarke and Carbon collection (2, 46, 54) . By studying the expression of plasmids carrying this chromosomal insert in maxicells (35) and by determining its nucleotide sequence (37) , we identified the murG coding region as an open reading frame of 1,065 nucleotides theoretically coding for a moderately hydrophobic protein of 355 amino acids with a calculated molecular weight of 37, 771 .
The aim of the present study was to investigate in more detail the physiological properties of the murG gene product in order to determine its role in peptidoglycan synthesis or cell division. In this report, the participation of the murG gene product in the membrane steps of peptidoglycan synthesis is clearly established. In particular, the phospho- 
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The E.
coli strains used throughout this study are shown in Table 1 . Plasmid pLC26-6 from the Clarke and Carbon collection (2) was a gift of B. Bachmann, and plasmid vectors pUC18 and pUC19 were obtained from Pharmacia (Uppsala, Sweden). Plasmid pJP900, constructed by insertion of the 2.4-kbp XhoII-XhoII fragment of bacteriophage lambda that carries the PR promoter, the cro ribosome-binding site, and the structural gene cI857 encoding a thermosensitive form of the lambda cI repressor into the BamHI site of the pUC9 vector, was a generous gift from J. Pla (CSIC, Universidad Aut6noma de Madrid, Spain). 2YT (i.e., 2 x YT) medium (42) or minimal medium M63 (42) supplemented with glucose (0.4%) was used for growing cells. When required, thymine (100 ,ug ml-'), L-amino acids (100 ,ug ml-'), ampicillin (100 ,ug ml-'), or kanamycin (25 ,ug ml-') was added. In most cases, 2-liter flasks containing 500 ml of medium were inoculated with 0.5 ml of overnight precultures and growth was monitored by measuring the optical density at 600 nm (OD6.) with a spectrophotometer (model 240; Gilford Instrument Laboratories, Inc., Oberlin, Ohio). Broth for plates was solidified with 1.5% agar. When screening plasmid inserts for the absence of a-complementation, X-Gal (5-bromo-4-chloro-3-indolyl-p-D-galactopyranoside) and IPTG (isopropyl-P-Dthiogalactopyranoside) were added at final concentrations of 40 ,ug ml-' and 40 jiM, respectively.
Recombinant DNA techniques and E. coli cell transformation. Small-and large-scale plasmid isolations were carried out by the alkaline lysis method (30) (36, 55) . At an OD of 0.1, cultures were divided into two portions: one portion was maintained at 30°C, and the other was transferred at 42°C. At an OD of 0.6, the alterations in cell shape characteristic of the murG mutant were controlled by optical microscopy, and meso-[3H]DAP was added to all cultures (18.5 kBq ml-', 888 GBq mmol-1).
After different labeling times (from 5 to 30 min), cell samples were analyzed by paper chromatography as described previously (15, 18, 24, 25, 48) . Briefly, cells from 10-ml culture samples were rapidly chilled to 0 to 4°C, collected by centrifugation, and suspended in 200 ,ul of ice-cold distilled water. Aliquots were applied to Whatman 3MM filter paper (50 cm long) and subjected to descending chromatography for 16 h in isobutyric acid-1 M NH40H (5:3) . Under such conditions, peptidoglycan remains at the origin and UDPMurNAc-peptides, DAP, and the mixture of lipid intermediates migrate with Rf values of 0.15, 0.4, and 0.9, respectively. As described previously (19, 48) , the determination of the relative amounts of UDP-MurNAc-peptides, lipid I, and lipid II required their selective extraction from the cell contents and the utilization of appropriate chromatographic procedures allowing their complete isolation and quantification. For this purpose, cells from 25 ml of culture labeled as described above were harvested, resuspended in 2 ml of boiling water, and maintained at 100°C for 15 min. After centrifugation of this suspension at 200,000 x g for 20 min, the pellet was extracted again with 2 ml of boiling water for 15 min. After centrifugation, both supernatants were pooled and the pellet was resuspended in 800 ,u1 of water. As demonstrated previously by Ramey and Ishiguro (48) , the pellet fraction contains peptidoglycan and lipid intermediates I and II and the supernatant contains DAP and the UDPMurNAc-peptides as labeled compounds. To determine the relative amounts of UDP-MurNAc-tripeptide and UDP-MurNAc-pentapeptide in this latter fraction, aliquots were analyzed as described previously (6) by HPLC by using a ,uBondapak C18 column and isocratic elution with a 0.05 M ammonium formate buffer, pH 3.70, at a flow rate of 0.5 ml min-'. Under these conditions, DAP, UDP-MurNAc-tripeptide, and UDP-MurNAc-pentapeptide were eluted in 10, 16, and 45 min, respectively. To determine the relative amounts of lipid I and lipid II in the pellet fraction, previously described procedures (19, 48) that involve a mild-acid hydrolysis of the extracted lipophilic compounds and a separation of the resulting MurNAc-pentapeptide and disaccharide-pentapeptide products by appropriate chromatographic procedures were essentially followed. In our case, the material was hydrolyzed in 10% acetic acid for 60 min at 105°C in sealed tubes (48) . The samples were lyophilized and, prior to chromatography, the muramyl residues of the muropeptides were reduced to their muramicitol derivatives (8) after 30 min of incubation at room temperature in 0.25 M sodium borate buffer, pH 9, containing 1 mg of sodium borohydride ml-1. The reaction was stopped by adjusting the pH to 3 with phosphoric acid, and HPLC of aliquots was done under the same conditions as those described above to separate the nucleotide precursors. Under these conditions, MurNAcpentapeptide and GlcNAc-MurNAc-pentapeptide were eluted at 19 and 35 min, respectively.
Preparation of crude envelopes. Plasmid-containing strains were grown under vigorous aeration in 2YT-ampicillin broth (50 ml) to an OD of 0.7 (250 mg of bacteria [dry weight] per liter of culture). Cells rapidly chilled in ice to 0 to 4°C were harvested under cold conditions, washed with 0.02 M potassium phosphate buffer (pH 7.0) containing 0.1 mM MgCl2 and 1 mM 2-mercaptoethanol, and centrifuged again. Final suspensions in 2.5 ml of the same buffer were sonicated in the cold until complete disruption of the cells. Cell debris was removed by centrifugation at 6,000 x g for 15 min, and the supernatant was centrifuged at 200,000 x g for 20 min in a TL-100 centrifuge (Beckman Instruments, Inc., Fullerton, Calif.). The resulting supernatants and pellets (particulate fractions) were analyzed for protein contents by the method of Lowry et al. (23) 
]Ala (0.4 GBq mmol-1), 0.5 mM UDP-GlcNAc, and membranes (90 ,ug of protein). Reaction mixtures were incubated for 5 to 60 min at 35°C. After incubation, samples were placed in a boiling water bath for 2 min, applied to Whatman 3MM filter paper, and subjected to descending chromatography for 16 h in isobutyric acid-1 M NH40H (5:3, vol/vol). Areas corresponding to peptidoglycan, UDPMurNAc-pentapeptide, and lipid intermediates were cut out and counted.
(ii) Transfer assay of phospho-MurNAc-pentapeptide translocase. The standard assay was performed essentially as described above with the exception that UDP-GlcNAc was omitted from the reaction mixture.
(iii) Exchange assay of phospho-MurNAc-pentapeptide translocase. As previously established (7, 10 min at 35°C to generate undecaprenyl-pyrophosphoryl-MurNAcpentapeptide before the addition of the radiolabeled substrate for 30 min at 35°C. Reaction mixtures were analyzed by paper chromatography as described above.
Labeling of proteins directed by plasmids. The maxicell method described by Sancar et al. (51) of labeling the proteins encoded by plasmids was used. In all cases, strain JM109 was used as the host for the plasmid to be tested and the procedure followed was as previously described (35) .
Complementation of mutations. The thermosensitive GS58 mutant was made competent as described previously (3) and transformed by the various plasmids to be tested. The cell suspension (200 p.I) mixed with DNA was kept on ice for 2 h before heating for 3 min at 42°C. Then, 400 p.1 of 2YT medium was added and cells were incubated at 30°C for over 1 h for expression of plasmid genes. Cells were recovered by centrifugation, and a final suspension made in 200 ,ul of 2YT medium was separated into two parts which were plated onto two prewarmed 2YT-ampicillin plates, one incubated at 30 and the other at 42°C. Growth was observed after 24 or 48 h of incubation.
RESULTS
Phenotypic properties of the murG mutant. The murG amber mutation studied throughout this work was originally discovered in a supF(Ts) background by Salmond et al. (50) . When cultures of a murG mutant strain (GS58) growing exponentially at 30°C are shifted to the nonpermissive temperature of 42°C, cells progressively lose their rod shape, become ovoid with a greatly increased volume (Fig. 1) , and finally lyse after a period that depends on the growth conditions used: 2 or 4 generation times after the temperature shift in 2YT medium or minimal medium, respectively ( Fig. 2 and 3) .
At 42°C, the thermosensitive mutation suppressor is inactivated and the newly made MurG protein molecules are consequently truncated. The fact that the alterations of cell shape and cell lysis only occur after a few hours could thus be explained by the time required for the inactivation of the suppressor as well as for the disappearance (progressive dilution or inactivation) of the functional MurG protein molecules still present at the time of the temperature shift.
murG codes for a 38K protein. The murG gene was recently more precisely located between the genes ftsW and murC (16, 35) within the left part of a 1.7-kbp SalI-KpnI fragment originating from the synthetic ColEl plasmid pLC26-6 from the Clarke and Carbon collection (2, 46, 54) . Different plasmids carrying chromosomal inserts derived from this SalI-KpnI fragment were constructed (Fig. 4) and analyzed for their capability to still complement the murG mutation of strain GS58 as well as to direct the formation of radioactive proteins in maxicell experiments. Plasmids pDML7, pDML8, pDML19, and pDML20 were previously described (35) . pLTG1 was constructed from pDML19 by an MIuI-PstI deletion, full filling-in of the resulting ends, and ligation. Plasmid pLTG7 was obtained by partial SmaI digestion of plasmid pDML7, and pMLD49 was obtained from pDML8 by internal SmaI deletion.
We have previously shown (35) that all the plasmids that carry in common the SalI-KpnI fragment express a radioactive protein with a molecular weight of 38,000 (38K protein) in maxicells. In addition, a 28K protein species could be observed, but only when this latter chromosomal insert was inserted in the wrong orientation, causing the minus strand to be under the vector lac promoter (lacZp) control. The results shown in Fig. 4 indicate that the murG gene begins between the MluI site and the leftmost SmaI site of the insert. Furthermore, it is clearly shown that the complementation of the murG mutation is always associated with the presence of only the 38K protein.
As suggested previously (35) , the 28K protein may correspond to a fusion protein resulting from reading through the vector into the sequence of the truncated murC gene, also present at the distal end of the SaIl-KpnI insert (13) . It was effectively observed that the 28K protein band was lost during expression in maxicells of plasmids in which the frame at this KpnI site, which is the junction between the insert and the pUC19 vector sequence, has been modified.
We have recently determined the nucleotide sequence of the 1.7-kbp SalI-Kpnl fragment (37 promoter, and an internal MIuI deletion into pMLD50 provided pLTG8, expressing only the murG gene (Fig. 5) .
When cultures of JM109(pLTG8) growing exponentially at 30°C in 2YT medium were shifted (at an OD of 0.1) to 42°C, an initial increase in the growth rate was observed, but growth rapidly stopped 2 h later when the OD of the culture reached a plateau value of 0.7. At this time, cells were recovered and their protein content was fractionated and analyzed as described in Materials and Methods. A very high accumulation of a 38K protein was observed in the cell content (Fig. 6 ). It comigrated with the radioactive protein band expressed in maxicells from plasmids carrying the murG gene. Furthermore, a typical fractionation procedure showed that the highly overproduced protein was mainly found in the particulate fraction, with only some traces in the soluble fraction (Fig. 6) . It was verified that the behavior of the protein in the fractionation experiment was normal and independent of its overproduction, by doing a similar fractionation protocol on maxicells of JM109(pDML19) expressing the radioactive murG gene product. The same results were obtained (data not shown).
Analysis of the particulate fraction by gel electrophoresis showed that the overproduced protein was migrating at a position where no other major membrane-associated protein was observed in extracts of control JM109(pJP900) cells grown at 30 or 42°C or in extracts of JM109(pLTG8) cells grown at 30°C (Fig. 6 ). In particular, this finding allowed us to directly recover the protein band from the gel and to determine its N-terminal amino acid sequence without any further purification step. The sequence obtained was S-G-Q-
G-K-?-L-M-V-M-A-G-G-T-G-G-H, which is in complete
agreement with the 5' end of the nucleotide sequence proposed for the murG gene (37) , taking into account a posttranslational loss of the terminal methionine residue. The murG-encoded protein thus has 354 amino acids and a molecular weight of 37, 640 . This result thus confirmed the correct assignment of the ATG initiation codon of the murG gene (37) that overlaps by 4 bases the end of the preceding ftsW gene (11) .
Involvement of the murG gene product in peptidoglycan synthesis. Since the temperature-dependent lysis exhibited by strain GS58 resembled the phenotypes of mutants defective in peptidoglycan synthesis (4, 26-28, 43, 53, 56) , the effect of a temperature upshift on peptidoglycan synthesis was determined. Two different methods to estimate the rate of synthesis of this macromolecule were used: (i) the measure of incorporation of radioactive DAP into the TCAprecipitable material, by using lysA derivative strains (deficient in DAP-decarboxylase) and (ii) the direct estimation of cell peptidoglycan content by amino acid and amino sugar analyses of isolated sacculi.
It was previously shown (36, 55) that the lysA-carrying strains were very convenient for following the kinetics of incorporation of labeled DAP into peptidoglycan and its different DAP-containing precursors. Indeed, these strains do not require DAP for growth and internalize almost completely the exogenously added radioactive DAP within 5 min (36, 55). Consequently, the specific radioactivity of DAP inside the cells is dependent only on the cell DAP pool value, which could be appropriately decreased by growing cells in the presence of methionine and threonine, as previously described (36) .
As shown in Fig. 3 , the rate of DAP incorporation into peptidoglycan decreased significantly in the mutant strain after 2 h of growth at 42°C. For the reasons expressed above, we have verified that the DAP pool values of both parental and mutant strains were equivalent and varied in a similar manner after a temperature shift (data not shown). It is noteworthy (Fig. 3) that the decrease in the rate of peptidoglycan synthesis and the subsequent loss of some peptidoglycan material were observed much earlier than the first effects on cell growth and the onset of lysis. This suggests that lysis was effectively a consequence of the inhibition of peptidoglycan synthesis.
Quite similar data were obtained by using the direct quantification of the macromolecule content in the cell (Table 2) . After 5 h of growth at 42°C, the peptidoglycan content of the murG cells appeared to be effectively 40% lower than that of parental cells grown in similar conditions. It could be assumed that the highly reduced peptidoglycan content determined in the mutant cells just before cell lysis occurs probably represents the lowest physiological value compatible with cell integrity.
Finally, since inactivation of the function of the murG gene product had the effect of decreasing the rate of peptidoglycan synthesis, we also investigated the effect of its overproduction in exponentially growing cells. In particular, the peptidoglycan content of cells harboring plasmid pDML19, in which the murG gene is under the control of the lac promoter (which overproduced fourfold the murG gene product [see Table 5 Effect of the murG mutation on peptidoglycan synthesis. OV2 lysA and GS58 lysA strains were grown exponentially at 300C in minimal medium supplemented with lysine. At an OD of 0.1 (arrow), the culture temperature was either maintained at 30°C or shifted to 42°C. At the same time, radioactive meso-[3H]DAP was added, and its incorporation into peptidoglycan (expressed in counts per minute per milliliter of culture) was measured as descnbed in Materials and Methods. Bacterial growth was followed in parallel by measuring the A6. of the culture. (A and C) OV2 lysA; (B and D) GS58 lysA. Symbols: 0, OV2 lysA at 30°C; *, OV2 lysA at 42°C; O, GS58 lysA at 30°C; *, GS58 lysA at 42°C. cytoplasmic step by determining the effect of its inactivation on the pool levels of the different cytoplasmic nucleotide precursors characteristic of this metabolic pathway. As shown in Table 3 , an arrest in the de novo synthesis of functional MurG protein molecules led to an increase of the pool levels of the two main cytoplasmic precursors, UDPGlcNAc and UDP-MurNAc-pentapeptide. No variation was observed in the pool of the other intermediate precursors from UDP-GlcNAc-enolpyruvate to UDP-MurNAc-tripeptide, which are always detected at a much lower pool level, as previously described (32, 33, 38) .
It was noteworthy that both accumulated compounds, UDP-GlcNAc and UDP-MurNAc-pentapeptide, were the substrates of the subsequent membrane steps of peptidoglycan synthesis. This result suggested that the mutational block was located downstream from UDP-MurNAc-pentapeptide in this metabolic pathway and consequently that the murG gene product was involved in a membrane step rather than in some early cytoplasmic step. This finding was in agreement with the subcellular localization of the corresponding protein recovered almost exclusively as a membrane-associated protein in the experiments described above.
To further localize the step blocked in the murG mutant, the cellular distribution of meso-[3H]DAP was determined in strains OV2 lysA and GS58 lysA grown at both permissive and nonpermissive temperatures. As shown in Table 4 with previous data from other laboratories (19, 48) and indicated that the pool level of the lipid intermediates was very low compared with that of the cytoplasmic nucleotide precursor. When looking at the differences observed between the two strains, it was noteworthy that the murG mutant strain grown at 42°C accumulated significant amounts of UDP-MurNAc-pentapeptide and to a lesser extent a lipid compound as labeled DAP-containing precursors (Table 4 ). This was in agreement with the increase in the pool level of the two major nucleotide precursors, UDPGlcNAc and UDP-MurNAc-pentapeptide, of this metabolic pathway observed in this strain during growth at 42°C (see above). The accumulation of labeling in lipid intermediates in this strain was very interesting, since it could be interpreted as a block either at the level of the second membrane reaction that catalyzes the synthesis of lipid II from lipid I or at the level of the utilization of lipid II by polymerization reactions. In all cases, it excluded the hypothesis of a block at the level of the first membrane reaction catalyzed by the phospho-MurNAc-pentapeptide translocase that would have had the effect of depleting the pool of both lipid intermediates. To differentiate between the two other hypotheses, the relative amounts of the two lipid intermediates in the respective labeled lipid fractions were determined by previously described procedures (19, 48) . As shown in Table 4 and Fig.  7 , a value of 0.37:1 was determined for the ratio between lipid I and lipid II in the parental strain OV2 lysA grown either at 30 or at 42°C or in the mutant strain GS58 lysA grown at 30°C. This finding was in agreement with the value of 0.33:1 recently estimated in strain MC4100 lysA by Kohlrausch et al. (19) or 0.3:1 to 0.6:1 determined previously for other lysA-carrying strains by Ramey and Ishiguro (48) . However, in considering the mutant strain grown at 42°C, this ratio was reversed and reached the considerably high value of 8.2:1 (Table 4 and Fig. 7) , a result indicating clearly that it was the step involved in the formation of lipid II from lipid I which was altered in the mutant at 42°C. Consequently, it could be deduced that the murG gene product was the UDP-GlcNAc:MurNAc-(pentapeptide)pyrophosphorylundecaprenol-GlcNAc-transferase which catalyzed the formation of lipid II from lipid I.
It was also noteworthy that the concentration ratio between UDP-MurNAc-pentapeptide and lipid I was found to be more or less constant, whatever the strain and the growth temperature used (from 110:1 to 140:1 [ 6 . Overproduction of a 38K protein in crude extracts from strain JM109(pLTG8). Strains JM109(pLTG8) and JM109 harboring the control plasmid pJP900 that does not contain the murG gene were grown exponentially at 30°C in rich 2YT medium. At an OD of 0.1, the culture temperature was either maintained at 30°C or shifted to 42°C. Cells were harvested 2 h later and were disrupted by sonication. As described in Materials and Methods, the protein contents of the soluble (S) and particulate (P) fractions obtained after high-speed centrifugation of the corresponding crude extracts were analyzed by SDS-PAGE. Molecular weight (mw) standards (thousands) indicated on the left are as follows: phosphorylase b (97.4), bovine serum albumin (69), ovalbumin (46) , and carbonic anhydrase (30) . The 38K protein, highly overproduced in the particulate fraction from JM109(pLTG8) after growth at 42°C, is indicated by the arrow on the right. such a constant ratio probably indicated that both the transfer and the reverse reactions were equilibrated in all cases.
Levels of translocase and transferase activities in membranes. To further substantiate these results, we determined the specific activities of the phospho-MurNAc-pentapeptide translocase and N-acetylglucosaminyl transferase in crude extracts of strains OV2 lysA and GS58 lysA. transferase was considerably lower in the mutant strain than in the parental strain. In fact, a decreased transferase level was already detected at 30°C, a result indicating that the amber mutation in murG has provoked a lower expression of the murG gene, modified the kinetic properties or the stability of the corresponding protein, or both. Moreover, it was demonstrated that a shift at 42°C was followed in the mutant strain by an arrest in the production of active transferase molecules: a 3.5-fold decrease in its specific activity was effectively observed in GS58 lysA cells after 4 h of growth at 42°C (Table 5) . Furthermore, the levels of both enzyme activities were determined in a strain carrying the pDML19 plasmid in which the murG gene is expressed under the control of the lac promoter. As shown in Table 5 , JM83 cells carrying pDML19 contained a normal level of translocase activity but fourfold-more transferase activity than cells carrying the pUC18 control vector.
These different results taken together therefore support our previous proposal that the product of murG corresponds to the N-acetylglucosaminyl transferase involved in the synthesis of lipid intermediate II.
DISCUSSION
The murG gene of E. coli was discovered previously (50) at 2 min on the chromosome within the cluster of genes from pbpB to envA that code for proteins involved in different aspects of peptidoglycan synthesis and cell division. Its involvement in a cell envelope-related function was deduced from the various alterations of cell shape that characterize the thermosensitive GS58 mutant strain under restrictive growth conditions. The absence of filamentation and the fact that cells apparently divide normally (50) It is noteworthy that the extent of accumulation of lipid I in the membrane was very poor compared with that of the cytoplasmic precursors UDP-GlcNAc and UDP-MurNAcpentapeptide located upstream in this metabolic pathway. This probably represents the maximum level at which this lipid intermediate could be accumulated in the membrane. Different hypotheses to explain this limited accumulation could be made. (i) It should be remembered that the biosynthesis of lipid I is dependent on the availability in the membrane of the undecaprenyl-phosphate carrier lipid, the level of which has never been determined in E. coli cells but which is generally assumed to be low (4, 19) . Moreover, this carrier lipid is not only utilized for peptidoglycan synthesis, since it is supposed to also participate in the synthesis of other cell envelope components such as lipopolysaccharides and enterobacterial common antigen (49) . (ii) Since the phospho-MurNAc translocase also catalyzes the reverse reaction (45) , the accumulation of lipid I is thus theoretically limited to a value defined by the equilibrium constant of both the transfer and reverse reactions, a hypothesis in total agreement with our finding that the ratio of concentrations existing between UDP-MurNAc-pentapeptide and lipid I remained more or less constant, whatever the strain and the growth conditions used.
The accumulation of UDP-MurNAc-pentapeptide previously observed (24, 25, 36) during treatments of E. coli and other bacteria by antibiotics (moenomycin, vancomycin, etc.) that block the utilization of lipid II by the subsequent polymerization reactions at a site located three steps downstream from this cytoplasmic nucleotide precursor in the peptidoglycan synthesis pathway is thus also consistent with a limited pool of lipid I.
The murG gene coding for the N-acetylglucosaminyl transferase involved in a membrane step of this metabolic pathway thus belongs to the same cluster as the genes involved in the synthesis of soluble precursors from UDPMurNAc to UDP-MurNAc-pentapeptide. It is noteworthy that the gene coding for the phospho-MurNAc-pentapeptide translocase activity has also been mapped recently within this particular chromosomal region between murF and murD and has been named ORF-Y (12) or mraY (14) .
As previously discussed (35) , all the genes from the pbpBenvA cluster that code for proteins involved in different cell envelope-related functions appear to be organized into many different transcriptional units, and the reason for the clustering of these genes is thus not immediately apparent. However, a clustering of the genes coding for peptidoglycan synthetases in the 2-min region is not a general feature: the genes murA (57) , coding for the phosphoenolpyruvate:UDPGlcNAc-enolpyruvyl transferase, and murB (26, 49) , also named mrbA (1, 43) , coding for the UDP-GlcNAc-enolpyruvate reductase, have been mapped in a completely separated region around 90 min.
